1. P538 Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study. (25th January 2019) Authors: Shavit-Brunschwig, Z; Ledder, O; Focht, G; Urlep, D; Lev-Tzion, R; Marcus, D; Broide, E; Assa, A; Hussey, S; Yerushalmy-Feler, A; Levine, A; Markowitz, J; Norden, C; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study. (30th January 2023) Authors: Atia, O; Shavit-Brunschwig, Z; Quteineh, A; Lev-Tzion, R; Stein, R; Broide, E; Urlep, D; Hyams, J; Aloi, M; Shouval, D S; Assa, A; Hussey, S; Markowitz, J; Yerushalmy, A; Miele, E; Russell, R K; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗